Stroke

China Medical System Gained Exclusive License of an Anti-Ischemic Stroke Class 1 Innovative Drug

Retrieved on: 
Thursday, August 24, 2023
Agreement, Post-stroke depression, CMS, Central nervous system, Marketing, Stroke, Y-3, NOS1, DSM-IV codes, Tablet, Incidence, Patient, Health, Phase, Family, Safety, Pharmaceutical industry

Y-3, a Class 1 Innovative Drug injection, is used to alleviate neurological symptoms and dysfunction of daily activities caused by acute ischemic stroke.

Key Points: 
  • Y-3, a Class 1 Innovative Drug injection, is used to alleviate neurological symptoms and dysfunction of daily activities caused by acute ischemic stroke.
  • After approved for marketing in China, it is expected to meet the clinical needs of drug with both safety and efficacy, providing new treatment options to ischemic stroke patients in China.
  • Y-3 Injection is a Class 1 innovative drug - small molecule compound, which is used to alleviate neurological symptoms and dysfunction of daily activities caused by acute ischemic stroke.
  • For further detailed information, please visit the following link for the announcement , “Voluntary and Business Update Announcement Gaining Exclusive License of an Anti-Ischemic Stroke Class 1 Innovative Drug” issued by CMS on August 24 2023.

OMRON Healthcare Sponsors ESC Congress 2023

Retrieved on: 
Thursday, August 24, 2023
Stroke, Hypertension, ECG, Recurrence, Viso, Patient, Cerebro, Atrial fibrillation, Pharmaceutical industry

The symposium will also introduce the latest study on detecting atrial fibrillation recurrence after ablation at home as well as a technique of diagnosing atrial fibrillation in 30 seconds and its advantages.

Key Points: 
  • The symposium will also introduce the latest study on detecting atrial fibrillation recurrence after ablation at home as well as a technique of diagnosing atrial fibrillation in 30 seconds and its advantages.
  • "Viso," an OMRON Healthcare remote patient-monitoring service, will also be showcased at the booth.
  • Aiming for zero cerebro-cardiovascular events, the Company has been working on advancing the ways of hypertension treatment in collaboration with healthcare professionals and researchers.
  • The Company will continue to promote academic activities globally, develop devices and services, and contribute to empowering people worldwide to live life to the fullest.

MEDICARDIA HEALTH INC. INCORPORATES WEARABLE ECG INTO ADVANCED REMOTE PATIENT MONITORING PLATFORM FOR ATRIAL FIBRILLATION SCREENING

Retrieved on: 
Wednesday, August 23, 2023
Stroke, Atrial fibrillation, Cardiovascular disease, Cardiac electrophysiology, MD, Patient, Risk, AF, FDA, Medical device, Pharmaceutical industry

MILWAUKEE, Aug. 23, 2023 /PRNewswire/ -- MediCardia Health announced the integration of wearable ECG from FDA registered consumer devices for use in remote monitoring of patients with and at risk for developing atrial fibrillation (AF).

Key Points: 
  • MILWAUKEE, Aug. 23, 2023 /PRNewswire/ -- MediCardia Health announced the integration of wearable ECG from FDA registered consumer devices for use in remote monitoring of patients with and at risk for developing atrial fibrillation (AF).
  • The advance marks an important milestone for the company in streamlining care of people with atrial fibrillation through remote monitoring and virtual care.
  • "Atrial fibrillation is the most common heart rhythm disorder, affecting more than 40 million people around the world.
  • Atrial fibrillation increases the risk of stroke five-fold and these strokes are often fatal or disabling, particularly because 25-40% of patients are not even aware they are in AF.

Common heart medication less effective in south Asian people – new research

Retrieved on: 
Wednesday, August 23, 2023
People, Heart, Male, Clopidogrel, Pacific Ocean, CYP2C19, East London Genes & Health, Stroke, Cardiovascular disease, Splenic infarction, Genetic testing, Prescription, Marker beacon, Patient, Risk, NHS, Group, Pharmaceutical industry, Vaccine, Gene

People who have recently had a heart attack are often prescribed clopidogrel, a medication that decreases the risk of having another heart attack.

Key Points: 
  • People who have recently had a heart attack are often prescribed clopidogrel, a medication that decreases the risk of having another heart attack.
  • While the drug is very effective at preventing subsequent heart attacks, it can only work if it’s activated by the body’s CYP2C19 enzyme.
  • For example, more than nine in every ten Indigenous people of the Pacific islands have one of these genetic variants.
  • Our new study has also shown that clopidogrel may not be effective for many British south Asians.

British Swim School Extends Vital Instruction to North Tampa

Retrieved on: 
Wednesday, August 23, 2023
Life, Safety, Teaching, Stroke, Death, Entrepreneurship, Risk, Water, International Red Cross and Red Crescent Movement, Survival, Cypress, Illusion, Research, Drowning, Little, Lake, Nursing, Tutoring

TAMPA, Fla., Aug. 23, 2023 /PRNewswire-PRWeb/ -- British Swim School, the nation's leading "learn to swim" franchise, is bringing their "Survival of the Littlest" mindset and exceptional service to North Tampa. Dr. Alicia Gayadeen recently opened British Swim School of North Tampa, located inside the Esporta Fitness at 5225 Cypress Preserve Drive.

Key Points: 
  • TAMPA, Fla., Aug. 23, 2023 /PRNewswire-PRWeb/ -- British Swim School , the nation's leading "learn to swim" franchise, is bringing their "Survival of the Littlest" mindset and exceptional service to North Tampa.
  • Dr. Alicia Gayadeen recently opened British Swim School of North Tampa, located inside the Esporta Fitness at 5225 Cypress Preserve Drive.
  • Alicia spent 17 years as a public school educator in South Florida before seeking entrepreneurship with British Swim School.
  • She shared that the model set by British Swim School and the desire to save lives aligned perfectly with her experience and beliefs.

Despite Fears to the Contrary, Canadian Wildfire Smoke Exposure Was Not Much Worse Than A Bad Pollen Day in New York City

Retrieved on: 
Wednesday, August 23, 2023
Mental Hygiene, New York State Department of Environmental Conservation, Asthma, Atmosphere, Critical Care Medicine (journal), Environmental protection, Stroke, NYU, Splenic infarction, New York University Grossman School of Medicine, Pollen, Inflammation, Sulfur, NYU Langone Health, New Yorker, Oxidative stress, American Journal, Soil, Doctor of Science, Population health, Smoke, Particulates, Copper, New York City Department of Health and Mental Hygiene, Potassium, Air pollution, American Journal of Respiratory and Critical Care Medicine, Pharmaceutical industry, Rare-earth element, Health, Medicine

NEW YORK, Aug. 23, 2023 /PRNewswire/ -- New Yorkers can apparently breathe a sigh of relief, at least for now.

Key Points: 
  • NEW YORK, Aug. 23, 2023 /PRNewswire/ -- New Yorkers can apparently breathe a sigh of relief, at least for now.
  • However, authors of a new study say other possible health effects, such as possible heart attacks and stroke, still need to be investigated.
  • The researchers caution that while no deaths tied to the wildfire smoke were reported in June, asthma remains a serious and potentially life-threatening lung disease.
  • Both are found in average New York City air and are known causes of oxidative stress when inhaled.

Head of Belgian Biotech Firm Wins Business Worldwide Magazine CEO Award

Retrieved on: 
Wednesday, August 23, 2023
Vaccine, GSK, Biotechnology, Bleeding, Stroke, Overalls, Tick, Cancer, Quality of life, ICH, Intraparenchymal hemorrhage, Infection, Inflammation, ViiV Healthcare, Science, Anticoagulant, Patient, Level, Risk, Blood, Myenteric plexus, Award, Neuroinflammation, Pharmaceutical industry, Birth control

LONDON, Aug. 23, 2023 /PRNewswire/ -- In the 2023 Business Worldwide Magazine CEO Awards, Marc Dechamps, the CEO of Belgian biotech firm Bioxodes, receives an acknowledgment as he is named 'Biotechnology CEO of the Year - Europe'.

Key Points: 
  • LONDON, Aug. 23, 2023 /PRNewswire/ -- In the 2023 Business Worldwide Magazine CEO Awards, Marc Dechamps, the CEO of Belgian biotech firm Bioxodes, receives an acknowledgment as he is named 'Biotechnology CEO of the Year - Europe'.
  • Marc Dechamps was the outright winner in his category, for his ground-breaking work in the field of thrombo-inflammation or stroke.
  • Unlike other business awards schemes that celebrate the overall successes of a company, here the spotlight is on the individuals who lead them.
  • The intention is to give worthy business leaders the recognition they deserve, while inspiring others to achieve similar successes.

Head of Belgian Biotech Firm Wins Business Worldwide Magazine CEO Award

Retrieved on: 
Wednesday, August 23, 2023
Vaccine, GSK, Biotechnology, Bleeding, Stroke, Overalls, Tick, Cancer, Quality of life, ICH, Intraparenchymal hemorrhage, Infection, Inflammation, ViiV Healthcare, Science, Anticoagulant, Patient, Level, Risk, Blood, Myenteric plexus, Award, Neuroinflammation, Pharmaceutical industry, Birth control

LONDON, Aug. 23, 2023 /PRNewswire/ -- In the 2023 Business Worldwide Magazine CEO Awards, Marc Dechamps, the CEO of Belgian biotech firm Bioxodes, receives an acknowledgment as he is named 'Biotechnology CEO of the Year - Europe'.

Key Points: 
  • LONDON, Aug. 23, 2023 /PRNewswire/ -- In the 2023 Business Worldwide Magazine CEO Awards, Marc Dechamps, the CEO of Belgian biotech firm Bioxodes, receives an acknowledgment as he is named 'Biotechnology CEO of the Year - Europe'.
  • Marc Dechamps was the outright winner in his category, for his ground-breaking work in the field of thrombo-inflammation or stroke.
  • Unlike other business awards schemes that celebrate the overall successes of a company, here the spotlight is on the individuals who lead them.
  • The intention is to give worthy business leaders the recognition they deserve, while inspiring others to achieve similar successes.

Great Speech and American TelePhysicians Announce Collaborative Partnership to Provide Virtual Speech Therapy Services to People of All Ages

Retrieved on: 
Tuesday, August 22, 2023
Data Management, Practice Management, Technology, Managed Care, Other Health, Health, Seniors, Medical Devices, Family, Consumer, Parenting, Anatomical pathology, Communication, Partnership, Friends, Speech, Spectrum, Physician, Stroke, ADHD, Quality of life, Multimedia, TBI, Neurology, Aphasia, Attention deficit hyperactivity disorder, Alzheimer's disease, Dementia, Parkinson's disease, Patient, ASD, Traumatic brain injury, Language, Diagnosis, Nursing

Great Speech , a leader in virtual speech therapy, and American TelePhysicians , a leading digital virtual care provider of neurology services under its NeuroX program, today announce a synergistic partnership to create access to an affordable online option for enhancing the skills of children, adults and seniors who need and seek better speech communications.

Key Points: 
  • Great Speech , a leader in virtual speech therapy, and American TelePhysicians , a leading digital virtual care provider of neurology services under its NeuroX program, today announce a synergistic partnership to create access to an affordable online option for enhancing the skills of children, adults and seniors who need and seek better speech communications.
  • CCC-SLP, founder and clinical director, Great Speech, emphasizes the profound impact of this collaboration, "The Great Speech approach to virtual care expands the robust portfolio of solutions offered by American TelePhysicians.
  • “Great Speech brings crucial speech and language therapy for patients with aphasia and other speech problems.
  • We are pleased to be working with Great Speech to improve our patients' quality of life."

Feel Sharp, Play Sharp: Gillette and Razer Team Up for the Ultimate Collaboration in Grooming and Gaming

Retrieved on: 
Tuesday, August 22, 2023
Hardware, Influencer, Consumer Electronics, Technology, Communications, Other Consumer, eSports, Sports, Men, Licensing (Entertainment), Electronic Games, Software, Licensing (Sports), Entertainment, Consumer, Male, Partnership, Life, Face, Culture, Stroke, Multimedia, History, Social media, Gillette, Video game, Razer

Gillette™, the world’s largest male grooming company, and Razer™, the world’s leading lifestyle brand for gamers, have teamed up to launch the ultimate collaboration in grooming and gaming.

Key Points: 
  • Gillette™, the world’s largest male grooming company, and Razer™, the world’s leading lifestyle brand for gamers, have teamed up to launch the ultimate collaboration in grooming and gaming.
  • View the full release here: https://www.businesswire.com/news/home/20230822417322/en/
    Feel Sharp, Play Sharp: Gillette and Razer Team Up for the Ultimate Collaboration in Grooming and Gaming.
  • “Razer, an elite gaming company, and Gillette, the world’s leading razor brand, is not just a naming coincidence,” said Daniel Ordonez, Global Brand Franchise Leader for Gillette.
  • For more information, please visit gillette.com/razer and follow Gillette Gaming on social media, including TikTok here , as well as Razer here .